Phase 2 EGFR Exon 20 Insertion Mutation Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer

Non-small Cell Lung CancerEGFR Exon 20 Insertion Mutation

BeBetter Med Inc200 enrolled2 locationsNCT06706713

Recruiting

Phase 2

To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy

Non-small Cell Lung CancerEGFR Exon 20 Insertion Mutation

Juan LI, MD20 enrolled1 locationNCT06192849